期刊文献+

灯盏细辛、黄芪注射液联合苯那普利治疗IgA肾病伴慢性肾功能不全 被引量:4

Fleabane injection combined with astragalin injection and benazepril in the treatment of patients with lgA nephropathy and chronic renal insufficiency
下载PDF
导出
摘要 目的观察灯盏细辛注射液及黄芪注射液联合苯那普利治疗IgA肾病(IgAN)伴慢性肾功能不全的临床效果。方法将86例Lee氏分级≥Ⅲ级伴肾功能不全的IgAN患者随机分为两组:灯盏细辛、黄芪注射液联合苯那普利组(联合组)和苯那普利组,观察两组的疗效。结果①1个月后,联合组24h尿蛋白定量明显下降(P<0.01),血白蛋白(A lb)水平升高(P<0.01),疗效优于苯那普利组。②1个月后,联合组BUN有一定程度下降(P<0.01),疗效优于苯那普利组;联合组和单用苯那普利组治疗后SCr比较,联合组明显低于苯那普利组(P<0.05)。结论灯盏细辛注射液及黄芪注射液联合苯那普利治疗IgA肾病(IgAN)伴慢性肾功能不全的患者,可以减轻蛋白尿,改善和稳定肾功能,疗效优于单用苯那普利者。 Objective To observe the clinical effect of fleabane injection combined with astragalin injection and benazepril in the treatment of patients with IgA nephropathy and chronic renal ,insufficiency. Methods Eighty - six cases of IgA nephropathy patients whose renal insufficiency worse than Ⅲ degree according to Lee classification were randomly divided into 2 groups-combinational group( fleabane injection combined' with astragalin injection and benazepril)and benazepril group(benazepril only). Their therapeutic effects were recorded and analysed. Results Twenty -.two hours quantitation of urine protein in the patients of combiational group decreased significantly ( P 〈0.01 ) , whereas blood albumin increased greatly ( P 〈0.01 ) one month after therapy. Meanwhile BUN decreased more in combinational group than that of benazepfil group ( P 〈 0.01 ). The SCr in combinational group were less than that of benazepril group post - treatmently ( P 〈 0. 05 ). Conclusion The schedule of fleabane injection combined with astragalin injection and benazepril can palliate albuminuria, ameliorate and stablize renal function of patients with IgA nephropathy and chronic renal insufficency,with a better therapeutic effect than using benazepril singly.
作者 郭永兵
出处 《中原医刊》 2006年第15期9-11,共3页 Central Plains Medical Journal
关键词 IGA肾病 血管紧张素转换酶抑制剂 灯盏细辛 黄芪 IgA nephropathy Angiotensin converting enzyme inhibitor Feabane Astragalin
  • 相关文献

参考文献8

二级参考文献12

  • 1徐光,张礼萍,沈慧芬,胡昌奇.野黄芩甙元及其类似物对蛋白激酶C的抑制作用[J].上海医科大学学报,1993,20(3):187-191. 被引量:141
  • 2Nishikawa T,Edelstein D,Du XL,et al.Normalization mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.Nature,2000,404:787-790.
  • 3Kitada M,Koya D,Sugimoto T,et al. Translocation of glomerular p47phox and p67phox by protein kinase C-activation is required for oxidative stress in diabetic nephropathy.Diabetes,2003,52:2603-2614.
  • 4Wilmer WA, Dixon CL, Herbert C. Chronic exposure of human mesangial cells to high glucose environment activates the p38MAPK pathway. Kidney Int, 2001, 60: 858-871.
  • 5Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes, 1995, 44:1139-1146.
  • 6Abdel-Wahab N, Yevdokimova N, Weston BS, et al. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J, 2001, 359: 77-87.
  • 7Koya D, Jirousek MR, Lin YW, et al. Characterization of protein kinase C β isoform activation on the gene expression of transformig growth factor-β1, extracellular matrix components, and protanoids in the glomeruli of diabetic rats. J Clin Invest, 1997, 100:115-126.
  • 8Allison A. Eddy. Molecular basis of renal fibrosis[J] 2000,Pediatric Nephrology(3-4):290~301
  • 9李英,吴文清,张益民,李红.野黄芪甙原对糖尿病大鼠肾脏蛋白激酶C活性作用的研究[J].中华肾脏病杂志,2000,16(2):89-91. 被引量:108
  • 10徐勇,黄颂敏,张敏,张海燕,樊均明,刘小菁.蛋白激酶C激活在高糖诱导肾系膜细胞中的作用[J].中华肾脏病杂志,2001,17(3):168-170. 被引量:8

共引文献154

同被引文献64

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部